House Votes Again to Condemn Trump's Military Actions Against Iran

The U.S. House of Representatives has once again voted to condemn President Trump's military actions against Iran, demanding he end the operations or seek explicit congressional authorization. This latest vote reflects a growing bipartisan opposition to Trump's escalation of military action in the Middle East without prior approval from Congress.

The non-binding resolution passed with 214 votes in favor and 208 against. Four Republican representatives, who had previously supported a similar war powers resolution with Democrats last month, again voted alongside Democrats. This vote comes after 12 consecutive nights of U.S. airstrikes against Iran, following the collapse of a ceasefire agreement.

The outcome highlights the widening rift between Republican lawmakers and the White House. As the war in Iran drags on, an increasing number of Republican representatives are publicly questioning the administration's lack of congressional authorization and consultation. They also criticize the Trump administration for failing to present a clear endgame strategy.

However, President Trump has shown no inclination to involve the legislative branch and shows little sign of scaling back military operations. Instead, he has continued to escalate his tough rhetoric, asserting his unlimited authority to continue military actions. Trump has largely ignored Congress's previous expressions of opposition, including similar resolutions passed by both the House and Senate last month, marking the first time lawmakers voted against the conflict since it began in February.

Meanwhile, House Republican leadership is pushing a budget plan to fund the war. Many Republicans are concerned that funding an unpopular, unauthorized conflict, which Congress has little effective oversight over, could put them at high political risk.

“

The U.S. House of Representatives again voted to condemn President Trump's military actions against Iran, demanding an end to the operations or explicit congressional authorization.